BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2021

Sep 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2021-09-20

Reporting Person: McKee Amy E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-20	Non-Qualified Stock Option	$15.02	A	53333	Acquired	2031-09-20	Common Stock (53333)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.

F2: The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021